1
|
Wehrli JM, Xia Y, Abivardi A, Kleim B, Bach DR. The impact of doxycycline on human contextual fear memory. Psychopharmacology (Berl) 2024; 241:1065-1077. [PMID: 38334789 PMCID: PMC11031495 DOI: 10.1007/s00213-024-06540-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Accepted: 01/20/2024] [Indexed: 02/10/2024]
Abstract
RATIONALE Previous work identified an attenuating effect of the matrix metalloproteinase (MMP) inhibitor doxycycline on fear memory consolidation. This may present a new mechanistic approach for the prevention of trauma-related disorders. However, so far, this has only been unambiguously demonstrated in a cued delay fear conditioning paradigm, in which a simple geometric cue predicted a temporally overlapping aversive outcome. This form of learning is mainly amygdala dependent. Psychological trauma often involves the encoding of contextual cues, which putatively necessitates partly different neural circuits including the hippocampus. The role of MMP signalling in the underlying neural pathways in humans is unknown. METHODS Here, we investigated the effect of doxycycline on configural fear conditioning in a double-blind placebo-controlled randomised trial with 100 (50 females) healthy human participants. RESULTS Our results show that participants successfully learned and retained, after 1 week, the context-shock association in both groups. We find no group difference in fear memory retention in either of our pre-registered outcome measures, startle eye-blink responses and pupil dilation. Contrary to expectations, we identified elevated fear-potentiated startle in the doxycycline group early in the recall test, compared to the placebo group. CONCLUSION Our results suggest that doxycycline does not substantially attenuate contextual fear memory. This might limit its potential for clinical application.
Collapse
Affiliation(s)
- Jelena M Wehrli
- Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 31, 8008, Zurich, Switzerland
| | - Yanfang Xia
- Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 31, 8008, Zurich, Switzerland
| | - Aslan Abivardi
- Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 31, 8008, Zurich, Switzerland
- Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, University of Oxford, FMRIB Building, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK
| | - Birgit Kleim
- Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 31, 8008, Zurich, Switzerland
| | - Dominik R Bach
- Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 31, 8008, Zurich, Switzerland.
- Wellcome Centre for Human Neuroimaging, University College London, Russell Square House, 10-12 Russell Square, London, WC1B 5EH, UK.
- Hertz Chair for Artificial Intelligence and Neuroscience, Transdisciplinary Research Area Life & Health , University of Bonn, Am Probsthof 49, 53121, Bonn, Germany.
| |
Collapse
|
2
|
Xia Y, Wehrli J, Gerster S, Kroes M, Houtekamer M, Bach DR. Measuring human context fear conditioning and retention after consolidation. Learn Mem 2023; 30:139-150. [PMID: 37553180 PMCID: PMC10519410 DOI: 10.1101/lm.053781.123] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2023] [Accepted: 07/06/2023] [Indexed: 08/10/2023]
Abstract
Fear conditioning is a laboratory paradigm commonly used to investigate aversive learning and memory. In context fear conditioning, a configuration of elemental cues (conditioned stimulus [CTX]) predicts an aversive event (unconditioned stimulus [US]). To quantify context fear acquisition in humans, previous work has used startle eyeblink responses (SEBRs), skin conductance responses (SCRs), and verbal reports, but different quantification methods have rarely been compared. Moreover, preclinical intervention studies mandate recall tests several days after acquisition, and it is unclear how to induce and measure context fear memory retention over such a time interval. First, we used a semi-immersive virtual reality paradigm. In two experiments (N = 23 and N = 28), we found successful declarative learning and memory retention over 7 d but no evidence of other conditioned responses. Next, we used a configural fear conditioning paradigm with five static room images as CTXs in two experiments (N = 29 and N = 24). Besides successful declarative learning and memory retention after 7 d, SCR and pupil dilation in response to CTX onset differentiated CTX+/CTX- during acquisition training, and SEBR and pupil dilation differentiated CTX+/CTX- during the recall test, with medium to large effect sizes for the most sensitive indices (SEBR: Hedge's g = 0.56 and g = 0.69; pupil dilation: Hedge's g = 0.99 and g = 0.88). Our results demonstrate that with a configural learning paradigm, context fear memory retention can be demonstrated over 7 d, and we provide robust and replicable measurement methods to this end.
Collapse
Affiliation(s)
- Yanfang Xia
- Computational Psychiatry Research, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, 8032 Zurich, Switzerland
| | - Jelena Wehrli
- Computational Psychiatry Research, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, 8032 Zurich, Switzerland
| | - Samuel Gerster
- Computational Psychiatry Research, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, 8032 Zurich, Switzerland
| | - Marijn Kroes
- Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen 6525 GA, the Netherlands
| | - Maxime Houtekamer
- Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen 6525 GA, the Netherlands
| | - Dominik R Bach
- Computational Psychiatry Research, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, 8032 Zurich, Switzerland
- Wellcome Centre for Human Neuroimaging, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, University College London, London WC1 3BG, United Kingdom
| |
Collapse
|